New Heart Transplant Method May Grow Donor Pool 30%
A study led by Duke Health physicians, including Jacob Schroder, MD, Assistant Professor of Surgery, found a relatively new method of heart transplantation, allowing the use of hearts donated after circulatory death (DCD), could expand the pool of available donor hearts by a projected 30%.
Duke Surgical Resident is Building a Medical Device Company
Muath Bishawi, MD, Cardiothoracic Surgery Resident, discusses his entrepreneurial journey developing a medical device that addresses and prevents the clogging of catheters.
John C. Haney, MD, Appointed Chair for Cardiothoracic Surgery at Mayo Clinic Jacksonville
John C. Haney, MD, MPH, Assistant Professor of Surgery, has accepted a position at Mayo Clinic in Jacksonville, Florida as the next Chair of Cardiothoracic Surgery. Dr. Haney’s final day in the Duke Department of Surgery will be September 30, 2023.
May Faculty Recognition
Perfusion Team Recognized with AmSECT’s Inaugural Pillar Award
Great COVID-19 Saves: How ECMO Helped a Pregnant Patient Meet Her Newborn Son
Photo above: Takia Morrison is discharged after recovering from COVID-19
When a baby is born, one of the first people they meet is their mother. For one newborn earlier this year, this was not the case, for his mother, Takia Morrison, was diagnosed with COVID-19. In the wake of the pandemic, caution and the safety of everyone is crucial, and a team at Duke University Hospital was ready to treat Ms. Morrison.
Duke Researchers Testing Novel Therapeutics for Early and Acute Stages of COVID-19
Duke Tests Novel COVID-19 Therapy, Is Lead Enroller in International Trial
The early stage of COVID-19 offers a critical window of opportunity to prevent the progression of the disease to the acute state, when patients require supportive care. By targeting the SARS-CoV-2 virus early on, a therapeutic can help to quickly eliminate the virus from the body while the patient’s symptoms are mild.